ListarDepartamento de Anatomía y Anatomía Patológica Comparadas y Toxicología por tema "Target therapy"
Mostrando ítems 1-2 de 2
-
Emerging Molecular Technologies in Renal Cell Carcinoma: Liquid Biopsy
(MDPI, 2019)Liquid biopsy, based on the circulating tumor cells (CTCs) and cell-free nucleic acids has potential applications at multiple points throughout the natural course of cancer, from diagnosis to follow-up. The advantages of ... -
Resistance to Systemic Agents in Renal Cell Carcinoma Predict and Overcome Genomic Strategies Adopted by Tumor
(MDPI, 2019)The development of new systemic agents has led us into a “golden era” of management of metastatic renal cell carcinoma (RCC). Certainly, the approval of immune-checkpoint inhibitors and the combination of these with ...